Knight Jeff E. 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 26, 2024
Insider Transaction Report
Form 4
Knight Jeff E.
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-03-22$45.39/sh−2,359$107,075→ 52,580 total - Exercise/Conversion
Common Stock
2024-03-22$23.98/sh+30,000$719,400→ 84,939 total - Sale
Common Stock
2024-03-22$44.22/sh−30,000$1,326,600→ 54,939 total - Exercise/Conversion
Stock Option (right to buy)
2024-03-22−30,000→ 130,000 totalExercise: $23.98Exp: 2031-09-01→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $44.22 per share. The range of sales prices on the transaction date was $44.00 to $44.52 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F2]The option is exercisable as follows: 25% of the shares subject to the option vest on August 30, 2022, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.